LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

Search

Quanterix Corp

Ouvert

SecteurSoins de santé

6.59 3.13

Résumé

Variation du prix de l'action

24h

Actuel

Min

6.34

Max

6.78

Chiffres clés

By Trading Economics

Revenu

-3.5M

-34M

Ventes

16M

40M

Marge bénéficiaire

-83.479

Employés

471

EBITDA

5.7M

-31M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+19.24% upside

Dividendes

By Dow Jones

Prochains Résultats

2 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

27M

265M

Ouverture précédente

3.46

Clôture précédente

6.59

Sentiment de l'Actualité

By Acuity

17%

83%

19 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Neutral Evidence

Quanterix Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 févr. 2026, 22:04 UTC

Résultats

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 févr. 2026, 23:55 UTC

Market Talk

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 févr. 2026, 23:40 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 févr. 2026, 23:37 UTC

Market Talk

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 févr. 2026, 23:32 UTC

Résultats

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 févr. 2026, 23:19 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 févr. 2026, 23:18 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 févr. 2026, 23:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

26 févr. 2026, 23:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 févr. 2026, 23:01 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 févr. 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 22:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 févr. 2026, 22:43 UTC

Market Talk

RBA Hike In March Is Being Underpriced -- Market Talk

26 févr. 2026, 22:33 UTC

Acquisitions, Fusions, Rachats

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 févr. 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 févr. 2026, 22:13 UTC

Market Talk
Acquisitions, Fusions, Rachats

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 févr. 2026, 21:59 UTC

Résultats

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 févr. 2026, 21:58 UTC

Acquisitions, Fusions, Rachats

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 févr. 2026, 21:49 UTC

Résultats

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 févr. 2026, 21:45 UTC

Résultats

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 févr. 2026, 21:44 UTC

Résultats

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 févr. 2026, 21:44 UTC

Résultats

Coles Expects Market to Remain Highly Competitive

26 févr. 2026, 21:44 UTC

Résultats

Coles Says Supermarket Customers Remain Value Oriented

26 févr. 2026, 21:43 UTC

Résultats

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 févr. 2026, 21:43 UTC

Résultats

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 févr. 2026, 21:42 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 févr. 2026, 21:41 UTC

Résultats
Acquisitions, Fusions, Rachats

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Comparaison

Variation de prix

Quanterix Corp prévision

Objectif de Prix

By TipRanks

19.24% hausse

Prévisions sur 12 Mois

Moyen 7.5 USD  19.24%

Haut 8 USD

Bas 7 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.34 / 6.015Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Bullish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

19 / 352Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat